Loading Events

3D Printing Manufacturing of drug delivery systems, medical devices, and implants

• Sep 22nd at 13:00 | Speakers: Thomas Kipping and Thomas Pollard | Chair: Atheer Awad

VIRTUAL MEETING – 22nd September 2022

Overview

The APS Emerging Technologies Focus Group, is pleased to announce their webinar which will offer plenty of opportunities for discussions. This meeting will bring together expert speakers from academia and industry and will include a talk from a junior researcher and a talk from a senior researcher from industry or academia.

Who should attend

This meeting is ideally suited for PhD Candidates, Academics, Industrialists, Specialist Technology Providers, and Regulatory Personnel. Overall, the content of this special series has been carefully crafted to complement the existing APS portfolio and the Emerging Technologies Focus Group hot topics.

Programme

22 September 2022 – 13.00-14.00 GMT
 
3D Printing Manufacturing of drug delivery systems, medical devices, and implants

Tickets

APS Members- Free
(Please get your code from the members hub for FREE tickets)

APS Student Members- Free
(Please get your code from the members hub for FREE tickets)

APS Non-Members- £15*

APS Student Non-Members- £10*

* All ticket prices exclude VAT

Dr. Thomas Kipping, Head of Drug Carriers at Merck KGaA Darmstadt, Germany

With a broad expertise in the field of solid dosage forms Thomas provides a deep understanding of formulation development and process optimization in the complex area of advanced manufacturing. He has a strong background in pharmaceutical industry including product development, GMP manufacturing, clinical supply and R&D.

Thomas is a pharmacist by education and holds a PhD in Pharmaceutical Technology.

 

Thomas Pollard

Tom is a PhD Research student at the University College London School of Pharmacy, working in the Basit Research Group. His work focusses on both biosensors and liquid printing. He has published multiple articles in these fields, including work on directly printing onto human nails for treatment of onychomycosis.
In 2019, Tom holds a MSc. in Physical Natural Sciences from the University of Cambridge.